Join StimulusBio at SITC 2024
From November 6–10, 2024, StimulusBio joined international leaders in Houston, TX, for the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC). The event brought together researchers, clinicians, and industry experts to share cutting-edge advancements in cancer immunology and immunotherapy.
At Booth #333, our team highlighted StimulusBio’s expertise in oncology clinical trials and the role of robust data analytics in accelerating the path from research to patient impact. With over 900 completed studies across all phases, we’ve built a strong foundation in supporting immunotherapy research and clinical development programs.
Throughout the meeting, our experts connected with attendees to explore how StimulusBio’s tools and strategies can help overcome challenges in trial design, technical validation, and clinical application.
We’re grateful to have been part of SITC’s leading forum advancing cancer immunotherapy and look forward to continuing collaborations that bring transformative therapies closer to patients.
📍 Booth #333
